Requests for Euthanasia & Assisted Suicide

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The study epiDESA2 identifies all explicit requests for euthanasia or assisted suicide expressed by the person him/herself, regardless of which professional is asked and regardless of where the request is made (primary care, health institutions, medico-social institutions including nursing home care or at home) in the Burgundy-Franche-Comté region during six months.

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT06186791` - Self-directed Dying in the Netherlands

NCT number	NCT02843776
Study type	Observational
Source	Centre Hospitalier Universitaire de Besancon
Contact
Status	Completed
Phase
Start date	January 1, 2017
Completion date	December 31, 2017

Requests for Euthanasia and Assisted Suicide — EPIDESA2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms